Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 28 April, 2020

JP Morgan Sec LLC

AbbVie Inc. 38.5(b)

RNS Number : 1732L
J.P. Morgan Securities LLC
28 April 2020
 

Ap27

 

 

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P Morgan Securities LLC

Companydealtin

AbbVie Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Common stock

Date of dealing

27 April 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

 12,013,826  0.81

 4,341,867  0.29

(2) Derivatives (other than options)

 3,942,583  0.27

 3,478,022  0.24

(3)Optionsandagreementstopurchase/sell

 756,700  0.05

 758,000  0.05

Total

 16,713,109  1.13

 8,577,889  0.58

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit (Note 4)

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

32

3

3

100

1,066

99

36

3

7

91

30

100

103

59

100

231

82

3

48

200

96

300

301

94

301

7

715

4

64

141

22

11,051

3

1,547

8,878

2,480

108

100

16,016

293

800

3

55

6

41

800

21

1,600

3,544

910

595

700

94

8

3

200

38

7

7

905

27

300

300

4

28

3

8

24

101

5

3

54

3

2

3

2

100

3

5

3

200

2

3

3

286

1,398

16

45

100

100

16

335,063

50

7

66

240

3

 

32

4,995

300

797

300

350

32

3,544

7

1

600

200

100

28

2

200

1,950

300

1,398

400

300

100

45

700

791

200

17,014

100

200

83.5900 USD

83.8400 USD

83.8500 USD

83.9800 USD

84.0877 USD

84.1000 USD

84.1183 USD

84.1355 USD

84.1365 USD

84.1416 USD

84.1495 USD

84.1500 USD

84.1900 USD

84.1986 USD

84.2000 USD

84.2100 USD

84.2105 USD

84.2200 USD

84.2400 USD

84.2438 USD

84.2441 USD

84.2453 USD

84.2495 USD

84.2567 USD

84.2665 USD

84.2700 USD

84.2748 USD

84.2800 USD

84.2867 USD

84.2889 USD

84.2943 USD

84.2973 USD

84.3000 USD

84.3026 USD

84.3054 USD

84.3059 USD

84.3091 USD

84.3100 USD

84.3129 USD

84.3130 USD

84.3150 USD

84.3160 USD

84.3190 USD

84.3200 USD

84.3218 USD

84.3266 USD

84.3267 USD

84.3294 USD

84.3319 USD

84.3376 USD

84.3400 USD

84.3689 USD

84.3693 USD

84.3784 USD

84.3818 USD

84.3838 USD

84.3874 USD

84.3900 USD

84.3929 USD

84.3952 USD

84.3975 USD

84.4016 USD

84.4050 USD

84.4824 USD

84.4889 USD

84.4900 USD

84.5121 USD

84.5131 USD

84.5200 USD

84.5202 USD

84.5308 USD

84.5327 USD

84.5373 USD

84.5405 USD

84.5568 USD

84.5588 USD

84.5708 USD

84.5779 USD

84.5891 USD

84.5900 USD

84.5950 USD

84.5951 USD

84.6092 USD

84.6200 USD

84.6293 USD

84.6314 USD

84.6388 USD

84.6600 USD

84.6624 USD

84.6700 USD

84.6736 USD

84.6900 USD

84.7000 USD

84.7200 USD

84.7324 USD

84.7453 USD

84.7500 USD

 

83.5900 USD

83.9969 USD

84.0100 USD

84.0124 USD

84.0333 USD

84.0800 USD

84.2700 USD

84.3319 USD

84.3929 USD

84.5200 USD

84.5356 USD

84.5500 USD

84.5600 USD

84.5700 USD

84.5900 USD

84.6100 USD

84.6115 USD

84.6200 USD

84.6314 USD

84.6361 USD

84.6400 USD

84.6500 USD

84.6600 USD

84.6629 USD

84.6637 USD

84.6700 USD

84.6900 USD

84.7000 USD

84.7378 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(USD)

(Note 4)

Equity Swaps

Long

 

Short

50

 

3,544

7

1,398

320,000

84.7000

 

84.3320

84.3929

84.6314

84.6900

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

(USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (USD)

(Note 4)

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Selling

Selling

Selling

Selling

Selling

Selling

Selling

Selling

Selling

700

1,300

300

1,200

13,900

3,000

2,100

1,600

200

72.50

75.00

75.00

77.50

77.50

77.50

77.50

80.00

80.00

American

American

American

American

American

American

American

American

American

18SEP20

18SEP20

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

18SEP20

18SEP20

3.35

3.95

4.00

4.75

2.13

2.15

2.19

5.65

5.75

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option 

referred   to   on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant 

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    YES

 

 

Dateofdisclosure

28 April 2020

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

 

 

 

 

 

 

Ap31

 

 

SUPPLEMENTAL   FORM   38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   38.5(b))   OPEN POSITIONS  (Note   1)

 

Productname,

e.g. call option

Written orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

10,000

6,100

41,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

8,500

10,000

100,000

50,000

15,000

15,000

20,000

7,900

9,500

8,500

6,100

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

20,000

15,000

15,000

20,000

102,500

31,300

32,300

16,400

65,000

900

7,000

4,400

45,000

29,100

9,700

4,900

12,100

12,100

800

140,000

5,100

3,000

600

20,000

15,000

15,000

20,000

102,500

31,300

32,300

11,400

8,900

1,900

4,400

29,100

20,000

100,000

15,000

15,000

20,000

1,600

1,200

700

1,800

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

105.00

110.00

70.00

92.50

91.57

95.93

82.37

95.00

100.00

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

82.50

91.57

95.93

82.37

60.00

65.00

70.00

75.00

77.50

85.00

72.50

67.50

80.00

55.00

60.00

65.00

70.00

75.00

77.50

82.50

62.50

72.50

67.50

80.00

78.49

82.85

78.35

60.00

65.00

70.00

75.00

77.50

72.50

67.50

55.00

60.00

70.00

78.49

82.85

78.35

75.00

77.50

72.50

80.00

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

18SEP20

18SEP20

 

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBGGDSXXDDGGI

a d v e r t i s e m e n t